• Contact us
Monday, October 5, 2026
Register
Login
European Press
ADVERTISEMENT Handpicked deals on Amazon Discover useful products selected for our readers. Explore deals ›
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video
No Result
View All Result
European Press
No Result
View All Result

Tadalafil linked to 22% higher glaucoma risk, study researchers find

23 August 2026
in Health
Reading Time: 2 mins read
A A
Tadalafil linked to 22% higher glaucoma risk, study researchers find
ShareShareShareShareShare


NEWYou can now listen to Fox News articles!
A drug used to treat erectile dysfunction and enlarged prostate symptoms may raise the risk of glaucoma, a serious eye condition that can cause gradual vision loss, according to new research. An international team of researchers analyzed health records from nearly 74,000 men ages 40 and older with lower urinary tract symptoms to examine whether long-term tadalafil use was associated with a greater risk of glaucoma. The study, published in the British Journal of Ophthalmology, compared about 37,000 men prescribed tadalafil with a similar group who did not use phosphodiesterase type 5 inhibitors, the drug class that includes Cialis.Researchers followed the men for up to five years and looked for new cases of glaucoma and high pressure inside the eye, along with whether patients needed treatment for glaucoma.VISION PROBLEM LEADS TO MAN’S STAGE 4 LUNG CANCER DIAGNOSIS, NEW DRUG EXTENDS SURVIVAL New research suggests tadalafil, the drug sold as Cialis for erectile dysfunction and enlarged prostate symptoms, may be linked to a higher risk of glaucoma. (iStock)Men who used tadalafil were 22% more likely to develop glaucoma than those who did not use the drugs, according to the findings.They were also 32% more likely to develop high pressure inside the eye and 33% more likely to develop primary open-angle glaucoma, the most common type of the disease.Dr. Valerie Kattouf, an optometrist at the Illinois Eye Institute who was not involved in the study, told Fox News Digital that glaucoma can be difficult to notice in its early stages.CLICK HERE FOR MORE HEALTH STORIES”Glaucoma is an eye condition that especially in its early stages often does not present with visual symptoms,” Kattouf said.As glaucoma progresses, people may gradually lose their side, or peripheral, vision, she said. The study found that men who used tadalafil were 22% more likely to develop glaucoma than men who did not take the drug. (iStock)”Clinical findings of glaucoma are best detected in a comprehensive vision evaluation,” Kattouf added.Kattouf said people with a family history of glaucoma, high pressure inside the eye or severe nearsightedness may face a higher risk. Those who take Cialis daily over a long period of time may also warrant closer monitoring, she said.CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTERPeople who regularly use the medication should have a comprehensive eye exam to establish a baseline for their eye health, according to Kattouf. Doctors can check pressure inside the eyes and perform other tests to look for changes that could signal glaucoma.The researchers noted several limitations to the study. People who take the medication regularly should get a thorough eye exam to establish a baseline for their eye health. (iStock)The study was observational, meaning it found a link between tadalafil use and glaucoma but could not prove that the medication caused the condition.Researchers also could not account for changes in medication use or other health conditions that developed over time.CLICK HERE TO DOWNLOAD THE FOX NEWS APPThe researchers stressed that the findings do not mean people should stop taking tadalafil. Instead, they said, patients who use the medication long term, particularly those with existing glaucoma risk factors, may benefit from regular eye monitoring.Fox News Digital reached out to Eli Lilly, the manufacturer of Cialis, and the study’s researchers for comment. Kelly McGreal is a production assistant with the lifestyle team at Fox News Digital. 

Credit: Source link

Previous Post

Matthew Stafford’s wife Kelly breaks out Jell-O shots for daughter’s birthday

Next Post

Latest news bulletin | August 18th, 2026 – Morning

Recommended

AstraZeneca considering PHL clinical ‘center of excellence’

AstraZeneca considering PHL clinical ‘center of excellence’

5 October 2026

THE Department of Trade and Industry (DTI) said it entered into a partnership with AstraZeneca PLC, which is considering establishing...

Cris Collinsworth has brutal Lions takedown after failed final chance

Cris Collinsworth has brutal Lions takedown after failed final chance

5 October 2026

Cris Collinsworth did not hold back for the Lions sake. During the “Sunday Night Football” matchup between the Panthers and...

Andrew Mountbatten-Windsor takes legal action over his arrest

Andrew Mountbatten-Windsor takes legal action over his arrest

5 October 2026

Andrew Mountbatten-Windsor has launched legal action over search warrants connected to his February arrest. The Telegraph first reported that his...

Best Pokémon TCG deal: the 30th Celebration Booster Bundle is  at Amazon

Best Pokémon TCG deal: the 30th Celebration Booster Bundle is $99 at Amazon

5 October 2026

TL;DR: The Pokémon TCG 30th Celebration Booster Bundle is in stock and available for $99 at Amazon. Credit: The Pokémon...

Datenschutzinformationen

Disclaimer  Privacy Policy – EU  Imprint 

Join European Press

Contact us

What’s New Here!

  • AstraZeneca considering PHL clinical ‘center of excellence’
  • Cris Collinsworth has brutal Lions takedown after failed final chance
  • Andrew Mountbatten-Windsor takes legal action over his arrest
  • Best Pokémon TCG deal: the 30th Celebration Booster Bundle is $99 at Amazon

We don’t spam! Read our privacy policy for more info.

Check your inbox or spam folder to confirm your subscription.

© 2026 European Press. All rights reserved.

European Press
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behaviour or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
No Result
View All Result
  • News
  • Business
  • Tech
  • Sport
  • Health
  • Media
  • Lifestyle
  • Video

© 2026 European Press. All rights reserved.

Not enough quota to unlock this post
Unlock left : 0
Are you sure want to cancel subscription?